| Dr Glenn J Green Jr, PHARMD | |
|
12a Westbank Expy Ste 101, Gretna, LA 70053-3659 | |
| (504) 509-5442 | |
| (504) 509-5421 |
| Full Name | Dr Glenn J Green Jr |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 12a Westbank Expy Ste 101, Gretna, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497078042 | NPI | - | NPPES |
| 1896870 | Medicaid | LA | |
| MA.000101 | Other | LA | MEDICATION ADMINISTRATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 45045 (Texas) | Secondary |
| 183500000X | Pharmacist | 17753 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn J Green Jr, PHARMD 4700 Wichers Dr, Suite 303, Marrero, LA 70072-3041 Ph: (504) 390-9135 | Dr Glenn J Green Jr, PHARMD 12a Westbank Expy Ste 101, Gretna, LA 70053-3659 Ph: (504) 509-5442 |
News Archive
Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.
CAS Medical Systems, Inc., today reported first quarter 2010 revenues of $8.5 million, an increase of $0.1 million, or 1%, compared to revenues of $8.4 million for the first quarter of 2009. The Company reported net income of $0.2 million, or $0.02 per basic and diluted common share, compared to a net loss of $0.9 million, or ($0.08) per basic and diluted common share, reported for the first quarter of the prior year.
The report by Trust for America's Health and the Robert Wood Johnson Foundation found that although some states have improved their preparedness, gaps persist largely because of state budget cuts.
Genomic Health, Inc. today announced positive results from the second large clinical validation study of Oncotype DX in patients with a pre-invasive form of breast cancer known as DCIS (ductal carcinoma in situ).
› Verified 8 days ago
Dr. Kristen Couvillion Laughlin, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 89 Westbank Expy, Gretna, LA 70053 Phone: 504-376-2349 | |
Demi Maria Peralta, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 Lapalco Blvd, Gretna, LA 70056 Phone: 504-393-7000 | |
Ibrahim A Abdelwahab, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Carol Sue Ave, Gretna, LA 70056 Phone: 504-366-1535 | |
Mrs. Ericka Martin, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 Morningside Dr, Gretna, LA 70056 Phone: 504-309-9556 | |
Dr. Edward Miller Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 66 Derbes Dr, Gretna, LA 70053 Phone: 504-366-6051 | |
Clarence Emanuel Venson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Carol Sue Ave, Gretna, LA 70056 Phone: 504-366-1535 | |
Mrs. Wendy Ann Ledet, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 89 Westbank Expressway, Gretna, LA 70053 Phone: 504-376-2349 Fax: 504-376-2498 |